Compounds > indazoles
Page last updated: 2024-08-21

indazoles and Rhabdomyosarcoma

indazoles has been researched along with Rhabdomyosarcoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasebe, N; Kabara, M; Maruyama, K; Matsuki, M; Nakagawa, N; Ogawa, Y; Shindo, M; Suzuki, A1
Hasegawa, T; Hashimoto, A; Hayashi, T; Hirayama, Y; Horiguchi, H; Iyama, S; Kato, J; Kitamura, H; Kobune, M; Masumori, N; Miyanishi, K; Murase, K; Nakanishi, K; Ono, K; Sato, T; Sato, Y; Takada, K; Takimoto, R; Tatekoshi, A1
Baruchel, S; Kerbel, RS; Kumar, S; Man, S; Mokhtari, RB; Oliveira, ID; Sheikh, R; Wu, B; Xu, P; Yeger, H; Zhang, L1
Houghton, PJ; Keir, ST; Kurmasheva, RT; Morton, CL; Smith, MA; Wu, J1

Other Studies

4 other study(ies) available for indazoles and Rhabdomyosarcoma

ArticleYear
Pazopanib-induced Endothelial Injury with Podocyte Changes.
    Internal medicine (Tokyo, Japan), 2018, Apr-01, Volume: 57, Issue:7

    Topics: Adult; Humans; Indazoles; Male; Nephrotic Syndrome; Podocytes; Proteinuria; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Rhabdomyosarcoma; Sulfonamides

2018
[Effective treatment of metastatic rhabdomyosarcoma with pazopanib].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:8

    Topics: Angiogenesis Inhibitors; Biopsy, Needle; Fatal Outcome; Female; Humans; Indazoles; Kidney Neoplasms; Middle Aged; Peritoneal Neoplasms; Pyrimidines; Rhabdomyosarcoma; Sulfonamides

2014
Metronomic oral topotecan with pazopanib is an active antiangiogenic regimen in mouse models of aggressive pediatric solid tumor.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Sep-01, Volume: 17, Issue:17

    Topics: Administration, Metronomic; Administration, Oral; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Endothelial Cells; Humans; Indazoles; Mice; Mice, Inbred NOD; Mice, SCID; Microvessels; Neoplasms; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Neuroblastoma; Osteosarcoma; Pyrimidines; Random Allocation; Rhabdomyosarcoma; Stem Cells; Sulfonamides; Topoisomerase I Inhibitors; Topotecan; Xenograft Model Antitumor Assays

2011
Initial testing of the multitargeted kinase inhibitor pazopanib by the Pediatric Preclinical Testing Program.
    Pediatric blood & cancer, 2012, Volume: 59, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Child; Child, Preschool; Female; Humans; Indazoles; Mice; Mice, SCID; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Rhabdomyosarcoma; Sarcoma, Ewing; Sulfonamides; Vascular Endothelial Growth Factors; Xenograft Model Antitumor Assays

2012